Terumo Medical Products (China Taiwan) has officially gone live with AlphaFlow's process automation platform to establish a unified and efficient digital process foundation for its Taiwan operations. This milestone marks an important expansion of the long-term collaboration between Terumo Group and AlphaFlow—extending the partnership from mainland China to China Taiwan and supporting more integrated operational management across Greater China.
The collaboration between AlphaFlow and Terumo dates back to June 2010. Over the past decade-plus, AlphaFlow has supported Terumo's subsidiaries across key mainland China regions including Shanghai, Zhejiang, and Beijing, delivering a total of 29 projects. This sustained partnership reflects both Terumo's commitment to long-term operational excellence and AlphaFlow's capability to support complex, large-scale enterprise scenarios with measurable value.
Founded in 1921, Terumo has grown into a global leader in medical technology and devices, serving customers in more than 150 countries and regions. The China Taiwan deployment builds upon proven practices established in mainland China and represents a meaningful step forward in Terumo's broader regional transformation agenda.
With the introduction of AlphaFlow BPMA (Business Process Management & Automation), Terumo Taiwan will strengthen operational execution through three key pillars:
Business processes are consolidated into a centralized entry point, reducing the need to switch across systems and lowering the adoption barrier for employees—helping drive higher participation and smoother execution.
AlphaFlow supports internationalized operations with capabilities such as multi-language and multi-time-zone adaptability, enabling better alignment with multinational organizational structures and geographically distributed teams.
By connecting PC and mobile experiences with real-time synchronization, AlphaFlow enables teams to handle process actions and approvals anytime, anywhere—improving organizational responsiveness and decision velocity.
Beyond direct efficiency improvements, AlphaFlow helps teams reduce repetitive work and focus more on high-value activities—while giving management clearer visibility into process bottlenecks and optimization opportunities. More importantly, the Taiwan of China rollout signals a shift toward more integrated regional operations within Terumo's APAC footprint.
As a key node in Terumo's APAC presence, China Taiwan benefits from mature healthcare infrastructure and strong talent. By adopting a platform already validated in mainland China, Terumo Taiwan can reduce transformation trial-and-error and accelerate standardization—strengthening cross-region collaboration and creating a more consistent data and process foundation for deeper operational synergy in the future.
Successful deployment in China Taiwan will also further validate AlphaFlow's adaptability across diverse market environments and may serve as a reference model for broader regional expansion of similar digital process initiatives.
Recommended Company News
